/CREMα
Tg mice. The impact of CREMα Tg on CLD progression was examined. Additionally, soft agar colony formation assays, in vitro studies, adoptive transfer of bone marrow-derived cells (BMDCs) and T cells, and gene arrays in T cells were performed. Results 
8-week-old Nemo
Δhepa /CREMα Tg mice presented significantly decreased transaminase levels, concomitant with reduced numbers of CD11b + dendritic cells and CD8 + T cells. CREMα Tg overexpression in Nemo Δhepa mice was associated with significantly reduced hepatic fibrogenesis and carcinogenesis at 52 weeks. Interestingly, hepatic stellate cell-derived retinoic acid induced a regulatory T-cell (Treg) phenotype in CREMα Tg hepatic T cells. Moreover, simultaneous adoptive transfer of BMDCs and T cells from CREMα
Tg into Nemo
Δhepa mice ameliorated markers of liver injury and hepatitis. Conclusions Our results demonstrate that overexpression of CREMα in T cells changes the inflammatory milieu, attenuating initiation and progression of CLD. Unexpectedly, our study indicates that CREMα transgenic T cells shift chronic inflammation in Nemo
Δhepa livers towards a protective Treg response.
INTRODUCTION
Sustained inflammation is a pathological hallmark of chronic liver disease (CLD) and promotes liver fibrosis and the growth of hepatocellular carcinoma (HCC). Th17 cells are a recently discovered subset of CD4 + T-helper cells characterised by the production of their signature cytokine interleukin 17 . Several lines of evidence have shown that Th17 cells are involved in the pathogenesis of different types of liver injury including alcoholic liver disease (ALD), non-alcoholic steatohepatitis, viral hepatitis and HCC development. 1 The cyclic AMP (cAMP)-responsive element modulator (CREM) belongs to the family of basic leucine zipper transcription factors. The α-isoform (CREMα) is the most abundant isoform in T cells and serves, due to the lack of a transactivation domain, as a transcriptional repressor. Together with the cAMP response element-binding protein,
Significance of this study
What is already known on this subject? How might it impact on clinical practice in the foreseeable future?
▸ To maintain a sufficient immune response, the timing and strength of immunosuppression have a major impact on inflammatory activity and end-stage cancer development. Therefore, our study demonstrates that the liver-specific inflammatory environment directs the response of regulatory T cells, which opens the basis for novel therapeutic strategies.
CREMα is a central mediator of T-cell proliferation by regulating IL-2 expression. 2 3 Indeed, repression of IL-2 production associated with increased CREMα mRNA and protein expression has been observed in T cells of patients with systemic lupus erythematosus. 3 4 Concomitantly, transgenic (Tg) mice overexpressing CREMα specifically in T cells (CREMα Tg ) are characterised by an increased binding of CREMα to the IL-2 promoter, leading to decreased IL-2 production and T-cell proliferation. 5 In experimental in vivo models of contact dermatitis and acute lung injury, as well as in vitro, CREMα-overexpressing mice cells display a Th17 phenotype, characterised by enhanced production of IL-17, IL-21 and IL-22 as well as retinoid receptor-related orphan receptor gamma-t (RORγt), promoting tissue inflammation and the recruitment of leukocytes, mainly neutrophils. [5] [6] [7] Aberrant nuclear factor-κB signalling plays a fundamental role in a wide range of inflammation-mediated diseases including rheumatoid arthritis, asthma and human cancers such as Hodgkin's lymphoma and colitis-associated cancer. 8 Knockout mice for the IKK complex members, IKKβ or NEMO, die in utero as a result of tumor necrosis factor (TNF)-mediated cell death of hepatocytes. Moreover, we have recently shown that hepatocytespecific Nemo knockout (Nemo Δhepa ) mice are viable but develop chronic liver injury characterised by TNF-dependent inflammation and scar formation leading to liver fibrosis, hepatitis and HCC within 1 year of age. 9 Hence, disease progression in this experimental animal model mimics the progression of human CLD.
In the current study we hypothesised that an increased Th17 response, caused by overexpression of CREMα, would exacerbate liver injury in Nemo Δhepa mice. However, we found ameliorated liver injury and reduced carcinogenesis. We, thus, analysed the underlying changes in disease progression and T-cell differentiation.
MATERIALS AND METHODS

Generation of nemo
Δhepa
/CREMα
Tg mice
Hepatocyte-specific IKK/Nemo knockout mice (Nemo Δhepa ) 10 were crossed to CD2-CREMα transgene-expressing mice (CREMα Tg mice) to generate Nemo Δhepa /CREMα Tg mice. CREMα Tg mice were crossed to non-CREMα Tg littermates for four generations. Cre littermates served as controls. Animals were housed under specific pathogen-free conditions in the animal facility of University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen. To investigate disease progression, male mice were sacrificed at 8, 13 and 52 weeks. All experiments were in line with the criteria of the authority for environment conservation and consumer protection of the state North Rhine-Westphalia (LANUV, Germany).
For details on methodology, please see online supplementary material.
RESULTS
CREMα ameliorates the onset of CLD in Nemo
Δhepa mice Since earlier studies suggested that activated Th17 cells and Th17-related cytokines play a prominent role in hepatic inflammation in human liver disease, we studied the impact of Th17 cells on initiation and progression of CLD. Therefore, we generated Nemo Δhepa /CREMα Tg animals by crossing Nemo Δhepa with Tg mice overexpressing CREMα specifically in T cells (CREMα Tg ) (see online supplementary figure S1A). To analyse the onset of CLD, we first assessed liver injury in 8-week-old mice. Nemo Δhepa mice are characterised by high levels of serum alanine (ALT) and aspartate transaminases (AST). In contrast, Nemo
Δhepa /CREMα Tg animals exhibited significantly reduced ALT and AST levels, indicating reduced liver injury in 8-week-old animals ( figure 1A ). H&E staining revealed only mild differences in hepatic damage between Nemo Δhepa /CREMα Tg and Nemo Δhepa mice (figure 1B, C), associated with a significantly decreased non-alcoholic fatty liver disease activity (NAS) score ( figure 1D ).
The pathogenesis of CLD in Nemo Δhepa mice is associated with increased hepatocyte apoptosis and compensatory proliferation. 9 11 Thus, we analysed the effect of CREMα overexpression in T cells using markers of cell death and proliferation in Nemo Δhepa / CREMα Tg livers. Immunostaining against cleaved caspase-3 (see figure 1E and online supplementary figure S1B) and Ki-67 (see figure 1F and online supplementary figure S1C) figure S1D ). However, the mRNA expression of proliferating cell nuclear antigen (Pcna), a specific S-phase cell-cycle marker, 12 Since chronic liver inflammation triggers liver fibrogenesis, we studied changes in hepatic collagen deposition and desmin expression as markers of hepatic stellate cell (HSC) activation. Collagen IA1 and desmin immunofluorescence and quantification and Sirius red staining (not shown) revealed significantly decreased markers of hepatic fibrogenesis in livers of 13- Therefore, we next focused on studying the impact of CREMα overexpression in T cells on tumour initiation and progression.
ALT levels were significantly reduced in 52-week-old Nemo Δhepa /CREMα Tg compared with Nemo Δhepa mice ( figure  3A ). Macroscopic liver examination revealed solid tumours in both Nemo
Δhepa and Nemo Δhepa /CREMα Tg mice (figure 3B). However, HCC was found in 100% of Nemo Δhepa mice, whereas it was detected in only 80% of Nemo Δhepa /CREMα Tg mice (see figure 3C ; lower panel and online supplementary figure S4A ). Furthermore, the liver-to-body weight ratio was significantly reduced in Nemo Δhepa /CREMα Tg compared with Nemo Δhepa mice, respectively ( figure 3C ; upper panel). Interestingly, the absolute as well as the relative area of HCC were significantly increased in Nemo
Δhepa compared with Nemo Δhepa /CREMα Tg mice (see figure 3C ; lower panel and online supplementary figure S4B ).
Both CD4 + and CD8 + T cells are mostly considered to be significant players in inhibiting, impeding and killing tumour cells. Moreover, it has been recently shown that loss of CD4 + T cells promotes HCC development. 13 To evaluate the immunosuppressive effect of cyclic AMP-responsive element modulator-α (CREMα) Tg 
from Nemo
Δhepa /CREMα Tg mice, but with a CREMα Tg phenotype, significantly reduced the tumourigenic capacity of Hepa 1-6 cells (see figure 3E , F and online supplementary figure  S4C ). These results question whether CD4 + T cells exert a crucial role in tumour development in Nemo Δhepa /CREMα Tg or decreased carcinogenesis is a secondary effect of the reduced inflammation observed in these livers.
Overexpression of CREMα in T cells reduces tumour malignancy in NEMO
Δhepa mice
Since 1-year Nemo Δhepa /CREMα Tg livers showed less HCC, and the impact of CREMα overexpression in T cells for tumour growth or malignant transformation and proliferation was further investigated in 52-week-old livers. Immunoblotting for PCNA, cyclin A and pRb revealed decreased protein expression Δhepa /CREMα Tg mice. After 21 days of incubation, colonies were stained with 0.01% crystal violet (scale bar: 1 and 5 mm). (F) The number of colonies was counted and shown in a graphic presentation of the soft agar colony formation assays of mean±SEM of triplicated experiments (***p<0.001). ALT, alanine aminotransferase; CREMα, cyclic AMP-responsive element modulator α; HCC, hepatocellular carcinoma; WT, wild type.
of these proliferation markers in Nemo
Δhepa /CREMα Tg compared with Nemo Δhepa livers (figure 4A). These data were confirmed by reduced figure 4C ). Additionally, western blot as well as immunostaining against glutamine synthetase, an enzyme shown to be upregulated in human and murine HCC tissue, 16 were enhanced in Nemo
Δhepa compared with Nemo Δhepa / CREMα Tg mice (see figure 4D and online supplementary figure  S4D) . Altogether, these results suggest that Tg overexpression of CREMα in T cells exerts a beneficial effect on tumour progression. -derived hepatocyte damage. Consequently, we investigated whether amelioration of CLD progression was caused by haematopoietic cells, and, especially, T cells. We, thus, performed adoptive transfer experiments. Six-week-old recipient mice were irradiated and transplanted with bone marrow-derived cells (BMDCs). In addition, these animals received a boost injection of T cells. As control, Nemo Δhepa mice received either WT or CREMα Tg BMDCs in order to verify the importance of the adoptive T-cell transfer. Mice were sacrificed 8 weeks later, and parameters of liver injury, hepatic inflammation and liver fibrosis were assessed, to analyse the impact of the transplanted cells ( figure 5A ).
Liver histology of transplanted mice revealed reduced liver damage in Nemo Δhepa mice receiving CREMα Tg cells, accompanied by significantly lower serum ALT values ( figure 5B, C) . This effect was more pronounced in animals that received BMDCs and T cells, indicating the crucial effect of pre-existing T cells. Furthermore, Nemo
Δhepa mice receiving CREMα Tg cells displayed significantly reduced collagen deposition as evidenced by Sirius red staining ( figure 5D, E) . Thus, haematopoietic-derived CREMα Tg T cells are essential to confer protection against CLD progression in NEMO Δhepa mice.
Overexpression of CREMα does not induce a predominant Th17 response in hepatic T cells
CREMα-overexpressing mice display a Th17 phenotype, characterised by enhanced production of IL-17, a proinflammatory as well as a profibrotic cytokine, 5 and manifest accelerated inflammatory response in in vivo models of contact dermatitis and acute lung injury. Surprisingly, Nemo
Δhepa /CREMα Tg mice showed reduced CLD progression. We, thus, examined the mRNA transcripts of the lineage transcription factor of Th17 cells, Rorγt, and their signature cytokine, IL17A, in 8-week-old CREMα Tg and Nemo Δhepa /CREMα Tg livers. Interestingly, T cells isolated from spleens of Nemo Δhepa /CREMα Tg mice showed a significant increase in Rorγt and IL17A mRNA expression ( figure 6A ).
Since we observed major differences in the effect of CREMα Tg T cells on the Nemo
Δhepa phenotype, associated with their differentiation pattern, 17 we further investigated the Th17 phenotype in hepatic T cells ( figure 6B) figure 6C, D) . Additionally, several markers of Treg function such as cytotoxic T-lymphocyte-associated protein 4 (ctla4), an inhibitory receptor, as well as Epstein-Barr virus induced-3 (ebi3), which encodes the IL-27β subunit of IL-35-a cytokine that suppresses inflammatory responses of immune cells, were strongly induced in hepatic T cells of Nemo Δhepa /CREMα Tg mice ( figure 6C, D) . In line with these findings, the T-cell immunoreceptor with Ig and immunoreceptor tyrosine-based inhibition motif (ITIM) domains (tigit), which is able to induce IL-10 production by DCs 18 and thereby mediate immune suppression, was strongly upregulated in hepatic T cells of Nemo Δhepa / CREMα Tg mice ( figure 6D ). Consistently, programmed cell death protein-1 (pdcd1), a surface receptor that prevents the activation of T cells by inhibiting Treg apoptosis, was also upregulated in hepatic T cells of Nemo
Δhepa
/CREMα
Tg and Nemo Δhepa mice ( figure 6D ).
To confirm our findings on protein level and to address the question whether the observed changes were specific for hepatic T cells, we performed FACS analysis using antibodies against FOXP3, CTLA4 and T-cell immunoglobulin domain and mucin domain 3 (TIM3) and further included blood-derived T cells in our analysis. TIM3 is widely regarded as a negative regulator of effector T-cell function and exhaustion and additionally has been shown to enhance the suppressor function of Tregs. 19 Our data showed a general increase in Treg-related markers (FOXP3, CTLA4 and TIM3) in hepatic T cells of 8-week-old Nemo Δhepa / CREMα Tg mice compared with blood-derived T cells (see figure  6E, F and online supplementary figure S7) . Moreover, the bioinformatics analysis of gene arrays revealed that T cells isolated from CREMα
Tg livers display upregulation of the IL-4 and IL-2 signalling pathways, involved in T-cell activation and differentiation into Th1, Th2 and Treg. CREMα-overexpressing T cells express high mRNA levels of LIGHT and CD40L associated with T-cell activation (see online supplementary figure S6A) .
Interestingly, liver Nemo Δhepa /CREMα Tg T cells exhibit upregulation of the CX3CR/CX3CL1 signalling pathway, a protective pathway in liver injury, 20 TREM2, which attenuates TLR4-dependent inflammation, and macrophage receptor with collagenous structure (MARCO), important in DCs (see online supplementary figure S6A). Furthermore, CREMα
Tg and Nemo Δhepa /CREMα Tg T cells show differential regulation of cytokine production by IL-17A and IL-17F (see online supplementary figure S6B) .
Altogether, our data suggest that the differentiation of T cells together with the activation of protective pathways such as the CX3CR/CX3CL1 confers protection against inflammation and tumourigenesis to Nemo Δhepa /CREMα Tg livers.
The inflammatory milieu in liver of Nemo Δhepa mice induces FOXP3 expression in CREMα-expressing T cells
After we observed reduced Rorγt + T cells in the liver, we tested the hypothesis that the inflammatory milieu in Nemo Δhepa livers might exert a direct effect on CREMα-expressing T cells. Based on previous publications 5 and to further corroborate the specificity of our results, we included splenic T cells in our experiment. Several studies indicate that activated HSC, especially during inflammation, function to enhance Treg differentiation. 21 In this scenario, an important soluble factor is RA; therefore, we analysed the mRNA expression of RA-related genes in WT and Nemo
Δhepa liver tissue. Indeed, we found upregulation of genes involved in RA metabolism including aldehyde dehydrogenase 1 family, member A1 (ALDH1A1), lecithin retinol acetyltransferase 1 (LRAT1), cellular RA binding protein 1 (CRABP1) and retinoc acid receptor (RAR)-α and RAR-β (figure 7A). To investigate whether HSC-derived RA contributes to the increase in FOXP3 in CREMα Tg mice, we isolated splenic T cells and cultured them with HSC SN and compared the differentiation pattern with T cells cultured under Th0 (without differentiation-inducing cytokines), Treg (TGF-β) or pronounced Treg (TGF-β+RA) conditions. While CREMα Tg T cells displayed a higher mean fluorescence intensity for FOXP3 under Th0 conditions-reflecting the figure S8A, B) .
To further evaluate the important role of RA in the TGF-β-dependent induction of FOXP3 + Treg and taking into account that the retinoic receptor (RAR)-α is involved in Treg induction, 22 23 we used RO415253, a specific inhibitor of RAR-α. RAR-α inhibition reduced the expression of FOXP3 almost to the level of T cells under Th0 conditions. We observed this effect in both WT and CREMα Tg T cells, suggesting a crucial role of RA in Treg induction (see figure 7B, C and online supplementary figure S8A, B) .
To determine whether increased amounts of Treg led to a reduction of other T-cell populations, we additionally assessed the production of signature cytokines IL-17 (Th17) and interferon γ (IFNγ) (Th1). While IL-17 levels showed no major differences under Th0 conditions, CREMα Tg T cells exhibited increased levels of IL-17 upon treatment with TGF-β+IL-6. SN from quiescent and activated HSC reduced the expression of IL-17, in both WT and CREMα Tg T cells (see online supplementary figure S9A, B) . Regarding Th1 differentiation, CREMα Tg T cells displayed slightly higher basal IFNγ levels, which were strongly diminished in both WT and CREMα Tg T cells upon treatment with TGF-β+IL-6. Alike to IL-17, treatment with SN from quiescent and activated HSC strongly reduced the levels of IFNγ (see online supplementary figure S9A, C) . Therefore, our data suggest a specific increase of FOXP3 expression and thus
Treg expansion in CREMα
Tg T cells stimulated with SN of activated HSC highly dependent on RA.
DISCUSSION
Nemo
Δhepa mice are characterised by the development of CLD, encompassing spontaneous hepatocyte apoptosis, compensatory proliferation, and finally leading to HCC development, a process where the strong inflammatory response plays a crucial role. In the current study, we aimed to investigate the impact of a stronger Th17 response, caused by overexpression of CREMα in T cells, on disease progression of Nemo Δhepa -dependent CLD. In contrast to our working hypothesis, we found reduced liver injury, hepatic fibrogenesis and tumourigenesis. Our data suggest that alterations in the expression pattern of molecules related to inhibitory T-cell function are essential to provide protection against CLD in this model.
CREMα-expressing T cells are characterised by the presence of a Th17 phenotype. In vitro, these cells show enhanced expression of the lineage transcription factor RORγt and the marker cytokines IL-17, IL-21 and IL-22. The present work provides evidence that the Th17 phenotype is altered upon hepatic injury. In accordance with previous publications, 5 T cells isolated from spleens of CREMα-expressing mice showed increased mRNA expression of RORγt and IL-17. Unexpectedly, the expression of RORγt in hepatic T cells was significantly downregulated in Nemo Δhepa /CREMα Tg mice. Th17 cells contribute to tissue damage by secreting cytokines such as IL-17 and IL-22 during liver fibrosis. 24 25 Th17 cells are not the only producers of IL-17, even though they represent the major source. Neutrophils, CD8
+ T cells and natural killer (NK) cells can also secrete IL-17. 26 27 Indeed, blockade of the IL-17 signalling has been shown to limit inflammation and subsequent hepatocyte damage in mice. 28 Inversely, increased IL-17 signalling exacerbates CCl 4 and bile duct ligation-induced liver fibrosis. 29 In contrast, regulatory T cells have been shown to suppress Th17-mediated inflammation through IL-10 signalling and STAT3. 30 31 Consequently, several studies have demonstrated that Tregs limit fibrosis development by suppressing excessive immune responses in the liver. 32 33 Thus, the increased frequency of Tregs in Nemo Δhepa /CREMα Tg mice might be responsible for the reduced number of Th17 cells.
The expression of CREMα under control of the CD2 promoter in mice has been shown to reduce the number and alter the composition of immune cells in the liver. 17 Previous work in our laboratory 34 In fact, BMDCs are responsible for the ameliorated liver injury and fibrogenesis in Nemo Δhepa /CREMα Tg mice. To functionally investigate our phenotype, we performed bone marrow transplantation in combination with an adoptive transfer of splenic T cells to boost the T-cell response. Nemo Δhepa mice reconstituted with CREMα BMDCs displayed a significant reduction in markers of liver injury and hepatic fibrogenesis, indicating that haematopoietic cells provide the CREMα-protective effect. It is tempting to speculate that this effect might be due to the induction of Tregs, potent inhibitors of inflammation. 35 However, more experiments need to be performed in order to address the definite role of CREMα in BMDCs, since in the current study, we focused on the role of the overexpression of CREMα in T cells.
Regulatory T cells represent a CD4 + population, which regulates immune responses. Treg can be either generated in the thymus (nTregs) or alternatively in the periphery (iTregs) (eg, the liver). 35 Importantly, Th17 cell and Treg development is a reciprocal process. Thus, the differentiation process of Th17 cells inhibits Treg differentiation and vice versa. 27 30 31 36 37 Indeed, we found increased mRNA and protein levels of lineage transcription factors such as FOXP3 in Nemo Δhepa /CREMα Tg . Moreover, our data show increased CTLA4 mRNA and protein expression, a molecule that has been linked with Treg function. 38 However, the induction of Treg-associated markers was characteristic for hepatic T cells but not blood-derived T cells. Interestingly, we were able to reproduce our findings in splenic T cells that were challenged with liver-derived soluble mediators. These intriguing results raised the question whether the inflammatory milieu in Nemo Δhepa livers exerted a regulatory effect on T cells expressing CREMα.
Several studies have indicated that inflammation-activated HSC enhances Treg differentiation through transdifferentiation into myofibroblasts. Concomitantly, our further functional analysis demonstrates that CREMα transgene expression increases the susceptibility of T cells for differentiation into Treg-during hepatic inflammation and HSC activation as shown by increased levels of FOXP3 in vivo and in vitro. Hence, the liver-specific inflammatory milieu has an impact in the status of T-cell differentiation.
As the disease progresses from hepatitis to HCC in NEMO Δhepa mice, T cells, both CD4 + and CD8 + , decrease in numbers with attenuated function and increased expression of inhibitory receptors during HCC. Increased frequencies of Treg, associated with tumour growth, poor prognosis and decreased survival rates, have been observed in patients with gastric and liver cancer. [39] [40] [41] Several findings in our model suggested that the lack of a predominant Tg livers. In summary, the effect of the CREMα transgene alters the ratio between Th17 and regulatory T cells, exerting an antiinflammatory and antitumourigenic effect in Nemo Δhepa livers. Thus, our present study shows that molecular defined immunosuppression is able to modulate inflammation-induced cancers and thus opens the gate to develop regulatory T-cell-based therapies for CLD patients. 
